Understanding RPL29: A Potential Drug Target Or Biomarker (G6159)

Target Name: RPL29

NCBI ID: G6159

RPL29

Understanding RPL29: A Potential Drug Target Or Biomarker

RPL29 (RPL29_3_370) is a gene that has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique genetic makeup and expression patterns make it an intriguing target for researchers to study.

The RPL29 gene is located on chromosome 16 and contains 29 exons. It is a part of the microRNA (miRNA) family, which is a group of non-coding RNAs that play a critical role in post-transcriptional gene regulation. miRNAs have been shown to regulate gene expression by binding to specific target genes and altering their stability.

RPL29 is unique due to its expression patterns. It is only expressed in the brain and nervous system, and its levels are highly regulated in these tissues. This is important for understanding how the brain and nervous system are involved in various physiological processes, including disease development and treatment.

The RPL29 gene has also been shown to be involved in several diseases and disorders. For example, it has been associated with various neurological disorders, including Alzheimer's disease, Parkinson's disease, and ALS. It has also been linked to cancer, with studies suggesting that RPL29 may be a potential therapeutic target for cancer cells.

In addition to its potential clinical applications, RPL29 is also a valuable research tool for understanding the underlying mechanisms of disease. Its unique expression patterns and involvement in several diseases make it a valuable model for studying gene function and disease.

Overall, RPL29 is a promising drug target or biomarker for a variety of diseases. Further research is needed to fully understand its potential and develop effective treatments.

Protein Name: Ribosomal Protein L29

Functions: Component of the large ribosomal subunit (PubMed:12962325, PubMed:23636399, PubMed:32669547). The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell (PubMed:12962325, PubMed:23636399, PubMed:32669547)

The "RPL29 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPL29 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets